Clinical Presentation, Diagnosis and Treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in Older Adults: A Review of the Evidence and its Implications for Clinical Care
Abstract
Although previously considered a disorder of childhood, studies in the last decade have demonstrated that attention-deficit hyperactivity disorder (ADHD) continues to impair function into adulthood and responds to pharmacotherapy. Due to age-specific changes in roles and challenges, it is possible that presentation and response to intervention may differ between older and younger adults. A literature search for papers that identified older adults with ADHD, including papers describing its epidemiology, manifestation, and treatment, was the basis for this paper. There is a paucity of data on ADHD in older adults; however, small observational studies have characterized the presence, impact, and treatment of ADHD in adults over the age of 50 years, and larger epidemiologic studies have demonstrated that ADHD symptoms exist in older adulthood. Optimal criteria for diagnosis of ADHD and methods of treating ADHD in older individuals have not been systematically explored. In light of the limited data, this review discusses considerations for differential diagnosis and safe pharmacotherapy of ADHD in older adults.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Most previous research has not found any decline of prevalence estimates with increasing age within adulthood, and ADHD prevalence in older adults (e.g., above 50 years) was estimated to be around 3%.
“Most previous research has not found any decline of prevalence estimates with increasing age within adulthood, and just as throughout adulthood in general, the ADHD prevalence in older adults (e.g., above 50 years of age) was estimated to be around 3% (Dobrosavljevic et al. 2020; Goodman et al. 2016; Guldberg-Kjar and Johansson 2009; Kooij et al. 2016; Michielsen et al. 2012; Sharma et al. 2021; T”
From ADHD and associated psychopathology in older adults in a German community sample (2023) · cites this paper as Goodman et al. 2016
The age cut-off of 50 years and older was chosen because previous studies have shown a growing number of people aged 50 or older being diagnosed with ADHD for the first time.
“The age cut-off ≥50 was chosen as previous studies have shown that there is a growing number of people aged 50 or older who are being diagnosed with ADHD for the first time (Goodman et al., 2016;Torgersen et al., 2016).”
From Prevalence of attention-deficit/hyperactivity disorder in older adults: a systematic review and meta-analysis (2020) · cites this paper as Goodman et al., 2016
ADHD is a neurodevelopmental disorder associated with multiple psychiatric and physical disorders that can persist into adulthood.
“Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder associated with multiple psychiatric and physical disorders that can persist into adulthood (Goodman et al., 2016;Nigg, 2013;Torgersen et al., 2016).”
From Prevalence of attention-deficit/hyperactivity disorder in older adults: a systematic review and meta-analysis (2020) · cites this paper as Goodman et al., 2016
Clinicians may lack awareness of the benefits of ADHD medication and of proper drug dosage in older adults.
“however, clinicians may lack awareness on the benefits and proper drug dosage in this age group (Goodman et al., 2016(Lensing et al., 2015).”
From Prevalence of attention-deficit/hyperactivity disorder in older adults: a systematic review and meta-analysis (2020) · cites this paper as Goodman et al., 2016
Some older adults who do not meet official clinical criteria for an ADHD diagnosis may experience distressing symptoms and may be in need for care.
“Additionally, some older adults who do not meet official clinical criteria for an ADHD diagnosis may experience distressing symptoms and may be in need for care (Goodman et al., 2016).”
From Prevalence of attention-deficit/hyperactivity disorder in older adults: a systematic review and meta-analysis (2020) · cites this paper as Goodman et al., 2016
Problems with attention, anterograde memory and executive functions are common in ADHD and age-related cognitive impairment, such as Mild cognitive impairment (MCI) or prodromal dementia.
“As problems with attention, anterograde memory and executive functions are common in ADHD and age related cognitive impairment, such as Mild cognitive impairment (MCI) or prodromal dementia (Goodman et al., 2016;Pollak, 2012)”
From Prevalence of attention-deficit/hyperactivity disorder in older adults: a systematic review and meta-analysis (2020) · cites this paper as Goodman et al., 2016
Older patients and/or their medical care providers may have concerns about potential ADHD medication side effects because of older age, comorbid psychiatric and somatic disorders (in particular cardiovascular conditions), and interactions with other medications.
“Additionally, older patients and/or their medical care providers may have concerns regarding potential ADHD medication side effects due to older age, comorbid psychiatric and somatic disorders (in particular cardiovascular conditions), and interactions with other medications (Goodman et al., 2016;Lensing et al., 2015;Brod et al., 2012;Herrmann et al., 2008).”
From Prevalence of attention-deficit/hyperactivity disorder in older adults: a systematic review and meta-analysis (2020) · cites this paper as Goodman et al., 2016
The citation lists haven’t been fetched yet
References 60 · Cited by 59
- Authors
- Goodman, D. W., Mitchell, S., Rhodewalt, L., & Surman, C. B. H.
- Affiliations
- Johns Hopkins University (US)
- Massachusetts General Hospital (US)
- Harvard University (US)
- Corresponding author
- Goodman, David W.
- ORCID
- Surman, Craig B. H.
- Venue
- Drugs & Aging
- Published
- 2015-12-11
- Volume
- 33
- Issue
- 1
- Pages
- 27-36
- ISSN
- 1170-229X (ISSN-L)
- 1179-1969
- OpenAlex
- W2195051588
- Cited by
- 59
- References
- 60
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 8 · 2023: 8 · 2022: 6 · 2021: 4 · 2020: 8 · 2019: 5 · 2018: 3 · 2017: 6
- FWCI
- 0.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Drugs & Aging (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- attention deficit hyperactivity disorder, older adults, ADHD diagnosis, ADHD medication, differential diagnosis, ADHD epidemiology
- MeSH terms
- Adult, Attention Deficit Disorder with Hyperactivity, Diagnosis, Differential, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review